Tennessee Healthcare Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tennessee Healthcare Today.

Press releases published on October 1, 2026

3 hours ago

White Paper Says Gyms Aren't Built for Women; Carbon Performance Says Its Gyms Are Designed for Everyone

Indeterminate EIN Presswire

9 hours ago

Nashville Concierge Medicine Announces New Content Explaining ADHD in Adults: Understanding Sleep and Focus

Indeterminate EIN Presswire

an hour ago

Artiva Biotherapeutics Highlights Updated AlloNK® Data in Sjögren Disease Presented at the 17th International Symposium on Sjögren’s Disease (ISSjD 2026)

Indeterminate GlobeNewswire

an hour ago

Helus Pharma Announces Completion of Legal Name Change

Indeterminate GlobeNewswire

an hour ago

Wave Life Sciences Announces FDA Feedback Supports Registrational Pathway for WVE-006 (RNA Editing) in AATD

Indeterminate GlobeNewswire

an hour ago

Arbutus Announces Final Results of Its US$230 Million Modified “Dutch Auction” Tender Offer

Indeterminate GlobeNewswire

an hour ago

InflaRx Appoints Gabriela Alperovich, MD, PhD, as Senior Vice President & Global Head of Clinical Development

Indeterminate GlobeNewswire

an hour ago

Galimedix Therapeutics presents baseline data from Phase 2 eDREAM trial highlighting patient-tailored microperimetry as a sensitive and precise functional measurement in geographic atrophy studies

Indeterminate GlobeNewswire

an hour ago

Sight Sciences to Debut the OMNI Ultra® Surgical System, the Latest Technology Advancement from the Pioneers of Ab Interno Canaloplasty, at the 2026 American Academy of Ophthalmology (AAO) Annual Meeting

Indeterminate GlobeNewswire

an hour ago

OrthoPediatrics Sponsors the 10th Pediatric Orthopedic Surgical Techniques Course

Indeterminate GlobeNewswire

an hour ago

Caspian Therapeutics Appoints Manasi Jaiman, M.D., M.P.H., and Elizabeth Mily to Board of Directors

Indeterminate GlobeNewswire

an hour ago

MitoRx Therapeutics presents new preclinical data on MTRX31, demonstrating restored mitochondrial density, at the 62nd EASD Annual Meeting

Indeterminate GlobeNewswire

an hour ago

What Are the 5 Signs of Poor Metabolic Health Adults May Overlook?

Indeterminate GlobeNewswire

an hour ago

Ocular Therapeutix™ to Participate in October Scientific and Investor Conferences

Indeterminate GlobeNewswire

an hour ago

Monte Rosa Therapeutics Announces Positive Results for MRT-8102 in GFORCE-1 Phase 1 Study Showing Normalization of Key Pathogenic Drivers of ASCVD in Subjects with Elevated CVD Risk

Indeterminate GlobeNewswire

an hour ago

Foghorn Therapeutics Provides Update on FHD-909 and Strategic Priorities

Indeterminate GlobeNewswire

an hour ago

Shattuck Labs Announces Phase 2 Clinical Trial of SL-325 in Hidradenitis Suppurativa and Appointment of Shoba Ravichandran, M.D., as Senior Vice President, Clinical Development

Indeterminate GlobeNewswire

an hour ago

Fate Therapeutics to Participate in Upcoming Fourth Quarter 2026 Conferences

Indeterminate GlobeNewswire

an hour ago

Kyntra Bio Appoints Andrew E. Singer, MBA to its Board of Directors

Indeterminate GlobeNewswire

an hour ago

Iovance Biotherapeutics Appoints Noah Berkowitz, M.D., Ph.D., as Chief Medical Officer

Indeterminate GlobeNewswire